Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
My main concern is that H2 Rev was £213mm, and RNS says dispute with DSC over contract and that may “materially” affect Q4 revenue. What does this mean? A huge repayment or extra charges and revenue due in? No idea but could in theory either double or wipe out and cash reserves.
That said, it’s positive that 50% revenue generated outside of DSC contract. Don’t get me wrong, I longed for major extension but glad we are not a one contract pony.
Lots of questions as to why no extension -
is product seen as not good enough? Doubtful.
Is product too expensive? Possible
Did the price get hiked after interest elsewhere? Possible
Did DSC just decide on a different approach at this point? Probably
Could DSC return? Possibly but depends on how deep the disagreement goes
Did BOD buy at <£7? Yes
Who are the only ones that really know what’s happening? BOD
Not a great day, but not one to cause a major sell off (after 12-7 one) and plenty to look forward too but certainly good news needed short term to stay relevant.
The SP has risen dramatically over last 12 months, people bandied about amazing numbers, the results didn’t quite match that and many sold as were hugely in profit and without above average results no surprise the SP is falling.
That said, if you ignore the mild disappointment and Clunky wording, results were exceptional with expanding output in numbers and range of product. Huge cash in bank will mean exciting times.
Has been a long, and at times painful, hold for me, and now will continue to be one until we see both sentiment and fair value return
GLA
I expect this to make gains this week in expectation of news.
Good news could see a large re-rate, average news may see small fall.
Mid to Long term I still see a lot of upside from this point.
If you feel there are other hotter stocks to chase sell and move there, or be patient and wait for the sp to naturally reflect what most here think it’s worth.
......nothing.
All fundamentals are still super positive, great product, huge revenues, massive upside potential in immediate term (literally any day is possible).
Many taking profits having sat on huge gains for a while. Most of these were shouting undervalued 4 days ago and we all expected £15+ . Nothing’s changed for me, sit tight and wait. Rise will come.
Not often we’ll see a company with guaranteed initial orders of over half their market cap for 6 months alone...... with a guaranteed and certified product the world needs.
May be the odd bump or retrace at times but double digits and more incoming in short term. ??
This is just England, rest of UK to come.
Care homes results and roll out to come.
More foreign go to orders expected.
Unbelievable potential for immediate sales.
How do you fairly price this up? £40 my get out spot??
Good discussion on fans getting back to football.
He talked of being invested in company with lateral flow tests hitting market with news imminently - reckon he's in a position to hear lots of gossip and news
Just a few points on MM’s from my experience
They will have strict risk parameters- thus won’t be able to hold large long positions overnight. This is especially relevant for AIM or non liquid markets.
They don’t read message boards - all banned from trade floors (inc twitter etc in general)
Sentiment does not exist, the Algos will work on numbers and factual input alone. Any non standard move would need risk approval which takes time.
They don’t make as much as you’d think in intraday trading- as liquidity providers (how they shield from reg rules on buying and selling / Dodd frank etc) they may even be loss leaders
With little to no SBL activity on these stocks MM’s even less likely to take or hold a position.
So..... they may be slimey gits but you can’t blame them for everything! GLA
Afraid I couldn’t take the chance as with smallish pot don’t want any tied up short term.
Sold at small loss, but would be over the moon to see BF eat his words and some of the more balanced posters reap some profits.
Good luck all.....it’s been a ride!
......is that the SP doesn't rise again significantly before a takeover and we don't see full value.
Based on other pharm sales I'd hope for purchase in region of $10bn. This factors in both lack of current revenues but also target market size and full phase 3 approval. Values of $2/3bn would turn out to be a steal.
Forget little swings and believe that this product does what it says and will potentially save millions of lives.
A by product is that the value will be massive and we all win long term.
Commenting on every penny move benefits nobody.
All imho and good luck- I continue to hold